Publication | Open Access
Comparison of the Impact of <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors
185
Citations
31
References
2016
Year
<sup>18</sup>F-FDG PET/CT had no clinical impact on G1 NETs and a moderate impact on G2 NETs. However, in poorly differentiated NETs, <sup>18</sup>F-FDG PET/CT plays a significant clinical role in combination with <sup>68</sup>Ga-DOTATATE. <sup>68</sup>Ga DOTATATE SUV<sub>max</sub> relates to grade and Ki-67 and can be used prognostically.
| Year | Citations | |
|---|---|---|
Page 1
Page 1